GB9921396D0 - Pharmaceutical formulation - Google Patents

Pharmaceutical formulation

Info

Publication number
GB9921396D0
GB9921396D0 GBGB9921396.9A GB9921396A GB9921396D0 GB 9921396 D0 GB9921396 D0 GB 9921396D0 GB 9921396 A GB9921396 A GB 9921396A GB 9921396 D0 GB9921396 D0 GB 9921396D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical formulation
formulation
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9921396.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GBGB9921396.9A priority Critical patent/GB9921396D0/en
Publication of GB9921396D0 publication Critical patent/GB9921396D0/en
Priority to JP2001522977A priority patent/JP2003509359A/en
Priority to AU70268/00A priority patent/AU7026800A/en
Priority to GB0328426A priority patent/GB2392164B/en
Priority to CA002446562A priority patent/CA2446562C/en
Priority to ES00958854T priority patent/ES2274803T3/en
Priority to GB0328773A priority patent/GB2392915B/en
Priority to US09/659,492 priority patent/US6479035B1/en
Priority to EP00958854A priority patent/EP1143930B8/en
Priority to GB0312326A priority patent/GB2385596B/en
Priority to DE60031504T priority patent/DE60031504T2/en
Priority to PCT/GB2000/003471 priority patent/WO2001019342A2/en
Priority to GB0022222A priority patent/GB2354007B/en
Priority to IT2000RM000491A priority patent/IT1317904B1/en
Priority to GB0320477A priority patent/GB2388843B/en
Priority to CA002486805A priority patent/CA2486805A1/en
Priority to CA002317999A priority patent/CA2317999C/en
Priority to AT00958854T priority patent/ATE343374T1/en
Priority to FR0011547A priority patent/FR2798290B1/en
Priority to FR0202756A priority patent/FR2820322B1/en
Priority to US10/198,364 priority patent/US6630129B2/en
Priority to US10/630,655 priority patent/US7220403B2/en
Priority to FR0309598A priority patent/FR2843882B1/en
Priority to FR0400541A priority patent/FR2848453B1/en
Priority to US10/774,393 priority patent/US20040157815A1/en
Ceased legal-status Critical Current

Links

GBGB9921396.9A 1999-09-11 1999-09-11 Pharmaceutical formulation Ceased GB9921396D0 (en)

Priority Applications (25)

Application Number Priority Date Filing Date Title
GBGB9921396.9A GB9921396D0 (en) 1999-09-11 1999-09-11 Pharmaceutical formulation
FR0011547A FR2798290B1 (en) 1999-09-11 2000-09-11 PHARMACEUTICAL FORMULATION OF FLUTICASONE PROPIONATE
GB0022222A GB2354007B (en) 1999-09-11 2000-09-11 Pharmaceutical formulation of fluticasone propionate
GB0320477A GB2388843B (en) 1999-09-11 2000-09-11 A metered dose inhaler containing a pharmaceutical formulation of fluticasone propionate
GB0328426A GB2392164B (en) 1999-09-11 2000-09-11 Pharmaceutical formulation of fluticasone propionate
CA002446562A CA2446562C (en) 1999-09-11 2000-09-11 Pharmaceutical formulation of fluticasone propionate
ES00958854T ES2274803T3 (en) 1999-09-11 2000-09-11 PHARMACEUTICAL FORMULATION OF FLUTICASONE PROPIONATE.
GB0328773A GB2392915B (en) 1999-09-11 2000-09-11 Pharmaceutical formulation of fluticasone propionate
US09/659,492 US6479035B1 (en) 1999-09-11 2000-09-11 Pharmaceutical formulation of fluticasone propionate
EP00958854A EP1143930B8 (en) 1999-09-11 2000-09-11 Pharmaceutical formulation of fluticasone propionate
GB0312326A GB2385596B (en) 1999-09-11 2000-09-11 Container for pharmaceutical formulation of fluticasone propionate
DE60031504T DE60031504T2 (en) 1999-09-11 2000-09-11 FLUTICASONPROPIONATE DRUG PREPARATION
PCT/GB2000/003471 WO2001019342A2 (en) 1999-09-11 2000-09-11 Pharmaceutical formulation of fluticasone propionate
JP2001522977A JP2003509359A (en) 1999-09-11 2000-09-11 Pharmaceutical formulation of fluticasone propionate
IT2000RM000491A IT1317904B1 (en) 1999-09-11 2000-09-11 PHARMACEUTICAL FORMULATION OF FLUTICASONE PROPIONATE.
AU70268/00A AU7026800A (en) 1999-09-11 2000-09-11 Pharmaceutical formulation of fluticasone propionate
CA002486805A CA2486805A1 (en) 1999-09-11 2000-09-11 A metered dose inhaler containing a pharmaceutical formulation of fluticasone propionate
CA002317999A CA2317999C (en) 1999-09-11 2000-09-11 Pharmaceutical formulation of fluticasone propionate
AT00958854T ATE343374T1 (en) 1999-09-11 2000-09-11 FLUTICASONE PROPIONATE MEDICINAL PREPARATION
FR0202756A FR2820322B1 (en) 1999-09-11 2002-03-05 PHARMACEUTICAL FORMULATION OF FLUTICASONE PROPIONATE
US10/198,364 US6630129B2 (en) 1999-09-11 2002-07-19 Pharmaceutical formulation of fluticasone propionate
US10/630,655 US7220403B2 (en) 1999-09-11 2003-07-31 Pharmaceutical formulation of fluticasone propionate
FR0309598A FR2843882B1 (en) 1999-09-11 2003-08-04 PHARMACEUTICAL FORMULATION OF FLUTICASONE PROPIONATE
FR0400541A FR2848453B1 (en) 1999-09-11 2004-01-21 PHARMACEUTICAL FORMULATION OF FLUTICASONE PROPIONATE
US10/774,393 US20040157815A1 (en) 1999-09-11 2004-02-10 Pharmaceutical formulation of fluticasone propionate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9921396.9A GB9921396D0 (en) 1999-09-11 1999-09-11 Pharmaceutical formulation

Publications (1)

Publication Number Publication Date
GB9921396D0 true GB9921396D0 (en) 1999-11-10

Family

ID=10860681

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9921396.9A Ceased GB9921396D0 (en) 1999-09-11 1999-09-11 Pharmaceutical formulation

Country Status (1)

Country Link
GB (1) GB9921396D0 (en)

Similar Documents

Publication Publication Date Title
PL351526A1 (en) Pharmaceutical formulation comprising amoxycillin
AU4328800A (en) Pharmaceutical formulation
EP1173216A4 (en) Pharmaceutical formulations
GB9818927D0 (en) Pharmaceutical formulation
IL148543A0 (en) Pharmaceutical carrier formulation
GB9909154D0 (en) Pharmaceutical formulation
GB9822333D0 (en) Pharmaceutical formulation
GB9926251D0 (en) Pharmaceutical formulation
GB9906126D0 (en) Pharmaceutical formulations
GB9930578D0 (en) Pharmaceutical formulations
GB9817470D0 (en) Pharmaceutical formulation
GB9802617D0 (en) Pharmaceutical formulation
GB9930700D0 (en) Pharmaceutical formulation
GB9917774D0 (en) Pharmaceutical formulation
GB9921396D0 (en) Pharmaceutical formulation
GB9910633D0 (en) Pharmaceutical formulation
GB9910636D0 (en) Pharmaceutical formulation
GB9917772D0 (en) Pharmaceutical formulation
GB9930878D0 (en) Pharmaceutical formulation
GB9927685D0 (en) Pharmaceutical formulation
GB9922187D0 (en) Pharmaceutical formulation
GB9917775D0 (en) Pharmaceutical formulation
GB9917777D0 (en) Pharmaceutical formulation
GB9919840D0 (en) Pharmaceutical formulation
EP1414417A4 (en) Pharmaceutical formulation

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)